ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 978,45
-0,98%
Dow Jones
38 852,86
-0,55%
DAX
18 561,14
-0,66%
Brent Oil
84,525
0,24%
Bitcoin
67 783,02
-0,74%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kindred Biosciences Inc (KIN)

  7. Kindred Biosciences Inc (KIN) Actualités

KIN

Kindred Biosciences (KIN)

Kindred Biosciences Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KIN
DateHeureSourceTitreSymboleSociété
14/02/202223h35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KINKindred Biosciences Inc
02/09/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KINKindred Biosciences Inc
31/08/202100h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KINKindred Biosciences Inc
30/08/202115h22Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KINKindred Biosciences Inc
30/08/202115h09Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:KINKindred Biosciences Inc
30/08/202115h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KINKindred Biosciences Inc
30/08/202115h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KINKindred Biosciences Inc
27/08/202123h37Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:KINKindred Biosciences Inc
10/08/202112h01Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)NASDAQ:KINKindred Biosciences Inc
05/08/202122h15Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KINKindred Biosciences Inc
21/07/202115h11Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:KINKindred Biosciences Inc
09/07/202123h31Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:KINKindred Biosciences Inc
25/06/202122h33Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KINKindred Biosciences Inc
25/06/202122h31Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:KINKindred Biosciences Inc
17/06/202100h45PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc.NASDAQ:KINKindred Biosciences Inc
16/06/202113h35Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:KINKindred Biosciences Inc
16/06/202112h30Business WireElanco Announces Agreement to Acquire Kindred BiosciencesNASDAQ:KINKindred Biosciences Inc
02/06/202114h31PR Newswire (US)Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Preventi...NASDAQ:KINKindred Biosciences Inc
25/05/202114h42PR Newswire (US)Kindred Biosciences to Present at Stifel 2021 Virtual Jaws & Paws Conference and LD Micro Invitational XINASDAQ:KINKindred Biosciences Inc
11/05/202122h03PR Newswire (US)Kindred Biosciences Announces First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
03/05/202114h42PR Newswire (US)Kindred Biosciences to Announce First Quarter 2021 Financial ResultsNASDAQ:KINKindred Biosciences Inc
29/04/202122h06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KINKindred Biosciences Inc
28/04/202114h32PR Newswire (US)Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy IndicationNASDAQ:KINKindred Biosciences Inc
20/04/202122h03PR Newswire (US)Kindred Biosciences Unveils Positive Results from its Long-Acting Interleukin-31 Antibody PK StudyNASDAQ:KINKindred Biosciences Inc
01/04/202123h14Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KINKindred Biosciences Inc
16/03/202121h02PR Newswire (US)Kindred Biosciences Announces Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
08/03/202114h32PR Newswire (US)Kindred Biosciences to Announce Fourth Quarter and Full Year 2020 Financial ResultsNASDAQ:KINKindred Biosciences Inc
02/03/202114h31PR Newswire (US)Kindred Biosciences to Present at Barclays Global Healthcare Conference and H.C. Wainwright Global Life Sciences ConferenceNASDAQ:KINKindred Biosciences Inc
25/02/202114h01PR Newswire (US)Kindred Biosciences Announces Submission of Parvovirus Monoclonal Antibody Data for Prophylactic IndicationNASDAQ:KINKindred Biosciences Inc
16/02/202122h02PR Newswire (US)Kindred Biosciences to Present at the BofA Securities Animal Health Virtual SummitNASDAQ:KINKindred Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:KIN

Dernières Valeurs Consultées

LSE
RC96
Citi Fun 25
NYSE
FBRT
Franklin BSP Realty
BINA
WINBRL
WINkLink
AMEX
RSPG
Invesco S&P 500 Equal We...
BIT
UC4604
Unicredit Bank
USOTC
TSPG
TGI Solar Power (PK)
NASDAQ
SJVAX
Steward Large Cap Value ...
BIT
P1S716
BNP Paribas Issuance
TSXV
KDR
XE
WSU
Washtec
USOTC
TASEF
Tasman Resources NL (PK)
COIN
FRNUSD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés